Insights Across Latest Advancements for Chronic Pain Management and COVID-19 Testing
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent innovations in digital health, microbiome, and flu vaccines technologies. The TOE also provides insights across latest advancements for chronic pain management and COVID-19 testing.
The TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Table of Contents
- Growth Opportunities in Digital, Microbiome-Based, and Preventive Healthcare Technologies
- Innovations in Life Sciences, Health & Wellness
- Molomics, Barcelona, Spain - Growth Opportunities
- Repurpose.AI, US - Growth Opportunities
- Cyclica Rx, Canada - Growth Opportunities
- Biondvax, Israel - Growth Opportunities
- Flugen Inc. US - Growth Opportunities
- Imutex, UK - Growth Opportunities
- Blue Water Vaccines Inc. US - Growth Opportunities
- Seqirus Ltd. UK - Growth Opportunities
- Iqur Limited, UK - Growth Opportunities
- Osivax, France - Growth Opportunities
- Vivaldi Biosciences, US - Growth Opportunities
- Emergex Vaccines Holding Ltd. UK - Growth Opportunities
- Adagio Therapeutics, US - Growth Opportunities
- Iggenix, US - Growth Opportunities
- Duke-Nus Medical School, Singapore - Growth Opportunities
- Biorelate, UK - Growth Opportunities
- Pieriandx, US - Growth Opportunities
- Blackthorn Therapeutics, US - Growth Opportunities
- Sangamo Therapeutics Inc. US - Growth Opportunities
- Seres Therapeutics Inc. US - Growth Opportunities
- American Gene Technologies Inc. US - Growth Opportunities
- F2G, UK - Growth Opportunities
- Kineta, US - Growth Opportunities
- DNA Script, France - Growth Opportunities
- Reapplix A/S, Denmark - Growth Opportunities
- Novozymes, Denmark - Growth Opportunities
- Key Contacts
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Adagio Therapeutics
- American Gene Technologies Inc.
- Biondvax
- Biorelate
- Blackthorn Therapeutics
- Blue Water Vaccines Inc.
- Cyclica Rx
- DNA Script
- Duke-Nus Medical School
- Emergex Vaccines Holding Ltd.
- F2G
- Flugen Inc. US
- Iggenix
- Imutex
- Iqur Limited
- Kineta
- Molomics
- Novozymes
- Osivax
- Pieriandx
- Reapplix A/S
- Repurpose.AI
- Sangamo Therapeutics Inc.
- Seqirus Ltd.
- Seres Therapeutics Inc.
- Vivaldi Biosciences
